Ligand Pharma (LGND) Tops Q4 EPS by 52c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Ligand Reports Fourth Quarter and Full Year 2018 Financial Results
February 7, 2019 4:01 PM EST
Conference Call Begins at 4:30 p.m. Eastern Time Today
Analyst
day to be held on Tuesday March 12 at 10:00 a.m. Eastern Time in New
York City
SAN DIEGO--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three and 12 months ended December 31, 2018, and provided an operating forecast and program updates. Ligand management will host a conference call today beginning at 4:30 p.m. Eastern time to discuss this announcement and answer questions.
The fourth quarter of 2018 capped off a year of superior... More
